Amprius Technologies (NYSE:AMPX – Get Free Report) had its target price boosted by equities research analysts at Oppenheimer ...

Proficio Capital Partners LLC bought a new position in shares of Bentley Systems, Incorporated (NASDAQ:BSY – Free Report) in ...

Nektar Therapeutics (NASDAQ:NKTR) operates as a biopharmaceutical company that discovers and develops therapies to treat ...

MOSCOW — USA Today sports columnist Christine Brennan will deliver the keynote address at the University of Idaho’s ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...

Christopher Nolan is an indie filmmaker at heart just with a massive budget, and he never listens to the studios. Will The ...

Jack Quaid has looked back on his time on the set of Christopher Nolan's Oppenheimer, revealing the acclaimed director paid ...

Akamai (AKAM – Research Report) received a Buy rating and a $100.00 price target from Oppenheimer analyst Param Singh today. The company’s ...

NeueHealth Inc (NEUE) is expected to report for 4Q. NeuroMetrix Inc (NURO) is expected to report for 4Q. Nikola Corp (NKLAQ) is expected to report for 4Q. Nu Ride Inc (NRDE) is expected to report for ...

Fintel reports that on March 19, 2025, Oppenheimer downgraded their outlook for Goldman Sachs Group (NYSE:GS) from Outperform ...

More than a year after Warner Bros. shelved “Coyote vs. Acme” for tax incentives, the Looney Tunes-inspired film is close to ...

Christopher Nolan is working on an adaption of Homer's epic poem "Odyssey" though it is not yet known how he plans to adapt ...